Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $33.6000 (3.7%) ($31.7200 - $33.8500) on Tue. Oct. 25, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.8% (three month average) | RSI | 46 | Latest Price | $33.6000(3.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.5% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(7%) SKYY(7%) XLF(7%) ARKK(6%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -1.9% in a week (0% probabilities). IPO(-6%) VIXM(-5%) TLT(-5%) SLV(-5%) GLD(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.9% (StdDev 3.8%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
5 Day Moving Average | $33.18(1.27%) | 10 Day Moving Average | $33.44(0.48%) | 20 Day Moving Average | $33.39(0.63%) | To recent high | -17.8% | To recent low | 6.3% | Market Cap | $662m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |